Table 2

Clinical Details of Patients

Patient no.

Age/sex

Survival after stroke

NIHSS on admission

Hypertensiona

Coronary artery disease

Atrial fibrillation

History of TIA/previous stroke

Hypercholesterolemiab

Smoking

Obesityc

Cause of death

Antiplatelets

Statinsd

RSA-be


1

63/F

2 days

26

Yes

No

No

No

No

No

No

Large ischemic stroke

No

No

Yes

2

84/M

3 days

21

Yes

Yes

No

No

No

Yes

No

Malignant stroke

No

No

No

3

68/M

3 days

24

Yes

Yes

No

No

Yes

No

No

Brain oedema

No

No

Yes

4

84/M

6 days

22

Yes

Yes

No

No

No

No

No

Cardiac failure

Yes

Yes

No

5

51/M

9 days

25

Yes

No

No

Yes

No

No

No

Respiratory infection

Yes

No

No

6

74/M

15 days

22

Yes

Yes

No

No

No

No

Yes

Heart attack

Yes

No

Yes

7

86/M

15 days

14

Yes

Yes

No

No

Yes

No

No

Urinary infection

Yes

No

No

8

58/M

17 days

16

Yes

Yes

No

No

Yes

Yes

No

Cardiac infarction

Yes

No

No

9

74/M

20 days

12

Yes

Yes

No

No

No

No

No

Bronchial aspiration

Yes

No

No

10

73/M

26 days

14

Yes

Yes

No

No

Yes

No

Yes

Respiratory infection

Yes

No

Yes

11

75/M

29 days

20

No

Yes

Yes

No

No

Yes

No

Septic shock

Yes

No

Yes

12

60/F

37 days

18

Yes

Yes

No

No

Yes

Yes

No

Pulmonary embolism

Yes

No

No


a Blood pressure greater than 135/85 mmHg.

b Serum total cholesterol levels greater than 5.2 mmol.

c Body mass index greater than 30.

d Patients who were on statins before the ischemic stroke.

e Patients taking either angiotensin converting enzyme inhibitors or angiotensin type I receptor antagonists.

M = male; F = female; NIHSS = NIH Stroke Scale; TIA = Transient Ischaemic Attack.

Mitsios et al. BMC Neuroscience 2007 8:93   doi:10.1186/1471-2202-8-93

Open Data